‌

US Patent 10828283 Treatment of hepatitis delta virus infection

Patent 10828283 was granted and assigned to Eiger BioPharmaceuticals on November, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Eiger BioPharmaceuticals

Current Assignee

Eiger BioPharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

10828283

Date of Patent

November 10, 2020

Patent Application Number

16052386

Date Filed

August 1, 2018

Patent Citations

‌

US Patent 10076512 Treatment of hepatitis delta virus infection

Patent Citations Received

‌

US Patent 11517532 Methods of treating hepatitis delta virus infection

‌

US Patent 11311519 Treatment of hepatitis delta virus infection

Patent Primary Examiner

‌

Gina C Justice

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10828283 Treatment of hepatitis delta virus infection

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API